As AI chip stocks stumble: Why is this analog maker still up 76% in a year?

Texas Instruments reported Q3 revenue of $6.06 billion, up 28% year over year, with gross margin at 64% and free cash flow of $8.4 billion over the trailing 12 months versus $2.4 billion a year earlier. Industrial sales rose more than 40%, data-center revenue about 95%, and Q4 revenue guidance of $5.8 billion–$6.3 billion exceeded analyst expectations; shares were nevertheless down 7.6% on November 5 amid a semiconductor sell-off. The article notes valuation and spending risks, including 2026 capital spending guided at $2 billion–$3 billion, while the consensus price target of $336.86 was about 21% above the cited $278.10 share price.

Analysis

The useful distinction is not “AI chips versus no AI chips,” but accelerator spending versus the broader build-out of power management and signal chains. That gives TXN exposure to data-center investment with potentially less direct dependence on winning the processor socket; it does not make TXN immune to a pause in data-center capex. Its industrial recovery is a separate, more cyclical leg, so inventory normalization—not AI enthusiasm alone—should determine whether the earnings rebound is durable.

The bullish cash-flow narrative needs adjustment: reported trailing FCF includes $1.6B of CHIPS Act incentives, while the fab-spending cycle is not finished and inventory is still elevated at 194 days. The 300mm cost advantage may support structural margins, but it cannot by itself establish near-term utilization or demand. At roughly 34x 2026 estimates, TXN already embeds meaningful execution; the multiple gap versus ADI is not proof of mispricing without comparable growth, cash conversion, and cycle data.

Near term, risk is a sentiment-driven semiconductor de-rating. Over 1–3 months, watch TXN guidance, industrial/auto inventory commentary, and capex updates. Over 6–18 months, moderating investment and better fab utilization could improve underlying FCF, but a prolonged inventory correction would defer that payoff. Contrarian point: analog is not simply a defensive AI beneficiary—its industrial recovery and valuation leave it exposed to a conventional semiconductor downturn. The promotional stock-selection claims are not independent evidence of durable alpha.

Key Decisions for Investors

• Avoid chasing TXN solely on the reported FCF rebound. Consider a staged long only if subsequent results show inventory days declining and underlying FCF—separated from incentive receipts—holding up as capex moderates.
• For a relative-value expression, consider a small long TXN / short AMD pair to reduce direct accelerator-spending exposure, not as a clean hedge: TXN still has data-center exposure, and the pair also carries distinct industrial-cycle and valuation risks. Reassess if TXN guidance weakens or AMD’s demand outlook stabilizes.
• Treat a failure to reduce inventory, a capex outlook persistently near the high end, or guidance below the stated range as thesis warnings; these would challenge the cash-conversion and recovery case and could pressure the premium multiple.
• Before trading TXN against ADI, verify comparable forward growth, inventory, capital intensity, and cash flow. The article’s relative P/E figures alone are insufficient to justify a pair trade.